NEW YORK (GenomeWeb) – Swedish diagnostic company Devyser has signed a distribution deal for its rapid prenatal aneuploidy diagnostic test kits in China with Dahui Biotech, the companies announced today.

Specific terms of the deal were not disclosed.

"There is an increasing demand for our prenatal diagnostic products in China," Devyser Founding Partner and CEO Ulf Klangby said in a statement. "Dahui Biotech's established distribution and service organization reaches genetic laboratories across China."

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.